Therapeutic Asset Ratings
1,553 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Iparomlimab
Immune Combination Therapy
JIANG LONGWEI
Early P1
C
(39)
Iparomlimab
Regorafenib
JIANG LONGWEI
Early P1
C
(39)
Irinotecan
Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Irinotecan
Circulating Tumor Cell
Second Affiliated Hospital of Nanchang University
Early P1
C
(39)
Isoproterenol
CAR T-Cell Therapy
University of Arizona
Early P1
C
(39)
Isoproterenol
Donor Lymphocyte Infusion
University of Arizona
Early P1
C
(39)
Isoproterenol
Disease Related To Hematopoietic Stem Cell Transplant
University of Arizona
Early P1
C
(39)
Isoproterenol
Vasodilation
University of Missouri-Columbia
Early P1
C
(39)
jd123
Acute Myeloid Leukemia
Peking University People's Hospital
Early P1
C
(39)
jd123
Acute Myeloid Leukemia Refractory
Peking University People's Hospital
Early P1
C
(39)
JK500 cells
Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Early P1
C
(39)
jy231
B-Cell Acute Lymphoblastic Leukemia
Affiliated Hospital of Guangdong Medical University
Early P1
C
(39)
jy231
B-Cell Non-Hodgkin Lymphoma
Affiliated Hospital of Guangdong Medical University
Early P1
C
(39)
Ketoconazole
Glioma
Universitas Padjadjaran
Early P1
C
(39)
Ketoconazole
Adult Glioblastoma
Milton S. Hershey Medical Center
Early P1
C
(39)
Ketoconazole
Brain Glioblastoma
Milton S. Hershey Medical Center
Early P1
C
(39)
Ketone Monoester
Systolic Heart Failure
The University of Texas Health Science Center at San Antonio
Early P1
C
(39)
kp405
Safety Issues
Kariya Pharmaceuticals
Early P1
C
(39)
kp405
Tolerance
Kariya Pharmaceuticals
Early P1
C
(39)
ksh01
Refractory Solid Tumors
TCRx Therapeutics Co.Ltd
Early P1
C
(39)
ksh01
TCR-T Cells
TCRx Therapeutics Co.Ltd
Early P1
C
(39)
ksx01-tcrt
Refractory Solid Tumors
TCRx Therapeutics Co.Ltd
Early P1
C
(39)
ksx01-tcrt
TCR-T Cells
TCRx Therapeutics Co.Ltd
Early P1
C
(39)
ksx01-tcrt cell therapy
Refractory Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Early P1
C
(39)
Lactobacillus Rhamnosus Gg
Spina Bifida
Medstar Health Research Institute
Early P1
C
(39)
Showing 576 to 600 of 1,553 assets
Previous
Page 24 of 63
Next
